Literature DB >> 16959587

Diabetic cardiomyopathy.

Gregg C Fonarow1, Preethi Srikanthan.   

Abstract

This article focuses on advances in the understanding of the pathogenesis and treatment of diabetic cardiomyopathy. Patients with diabetes are at an elevated risk for heart failure, and comorbid heart failure confers an increased risk of morbidity and mortality. Diabetic cardiomyopathy and to apply proven lifesaving therapies in all heart failure patients, including those with diabetes, in the absence of contraindications or intolerance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959587     DOI: 10.1016/j.ecl.2006.05.003

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  18 in total

1.  Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.

Authors:  Rosalinda Madonna; Yong-Jian Geng; Roberto Bolli; Gregg Rokosh; Peter Ferdinandy; Cam Patterson; Raffaele De Caterina
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

2.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

3.  Role of Bcl-2/adenovirus E1B 19 kDa-interacting protein 3 in myocardial cells in diabetes.

Authors:  Wenzhong Zhou; Jian Yang; D I Zhang; Fengyin Li; Guo Li; Yanyun Gu; Min Luo
Journal:  Exp Ther Med       Date:  2015-04-22       Impact factor: 2.447

Review 4.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

Review 5.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

Review 6.  Glycemic control and treatment patterns in patients with heart failure.

Authors:  W H Wilson Tang
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

7.  Lack of effects of pioglitazone on cardiac function in patients with type 2 diabetes and evidence of left ventricular diastolic dysfunction: a tissue doppler imaging study.

Authors:  Katerina K Naka; Konstantinos Pappas; Katerina Papathanassiou; Nikolaos D Papamichael; Nikolaos Kazakos; Chryssanthi Kanioglou; Demetrios Makriyiannis; Christos S Katsouras; Kostas Liveris; Agathocles Tsatsoulis; Lampros K Michalis
Journal:  Cardiovasc Diabetol       Date:  2010-09-23       Impact factor: 9.951

Review 8.  Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Authors:  Sergio Coccheri
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  [Heart failure in diabetes].

Authors:  Michael Resl; Martin Hülsmann; Richard Pacher; Martin Clodi
Journal:  Wien Med Wochenschr       Date:  2009

10.  A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II.

Authors:  Souad Belmadani; Juan Bernal; Chih-Chang Wei; Manuel A Pallero; Louis Dell'italia; Joanne E Murphy-Ullrich; Kathleen H Berecek
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.